Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-23-007247

CHIEF EXECUTIVE OFFICER sold 15,693 shares at an average $20.63 ($323,745)

  • CHIEF EXECUTIVE OFFICER acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

NOYES TIMOTHY P · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-01 Exercise or conversion : show line 1 in the form 10b5-1 +15,000 $2.14 $32,100 15,693 D
2023-05-01 Sale : show line 2 in the form 10b5-1 −15,000 $20.61 $309,089 693 D
2023-05-02 Sale : show line 3 in the form 10b5-1 −693 $21.15 $14,657 0 D
Open-market sales · 15,693 sh · avg $20.63 · $323,745

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-05-01 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −15,000 $2.14 2031-04-01 15,000 403,381 D
Loading xslF345X04/form4-05032023_060501.xml…